AllianceBernstein’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-2,052,554
| Closed | -$95.1M | – | 3207 |
|
2019
Q2 | $95.1M | Buy |
2,052,554
+1,618,805
| +373% | +$75M | 0.06% | 318 |
|
2019
Q1 | $10.6M | Sell |
433,749
-197,600
| -31% | -$4.82M | 0.01% | 1028 |
|
2018
Q4 | $9M | Sell |
631,349
-51,400
| -8% | -$732K | 0.01% | 1029 |
|
2018
Q3 | $10.4M | Buy |
682,749
+250,000
| +58% | +$3.8M | 0.01% | 957 |
|
2018
Q2 | $7.26M | Buy |
432,749
+940
| +0.2% | +$15.8K | 0.01% | 1079 |
|
2018
Q1 | $7.05M | Buy |
431,809
+69,980
| +19% | +$1.14M | 0.01% | 1050 |
|
2017
Q4 | $4.63M | Buy |
361,829
+105,000
| +41% | +$1.34M | ﹤0.01% | 1254 |
|
2017
Q3 | $3.16M | Hold |
256,829
| – | – | ﹤0.01% | 1507 |
|
2017
Q2 | $2.15M | Sell |
256,829
-68,950
| -21% | -$577K | ﹤0.01% | 1768 |
|
2017
Q1 | $2.91M | Buy |
325,779
+99,850
| +44% | +$893K | ﹤0.01% | 1526 |
|
2016
Q4 | $1.99M | Buy |
225,929
+27,600
| +14% | +$243K | ﹤0.01% | 1830 |
|
2016
Q3 | $1.34M | Hold |
198,329
| – | – | ﹤0.01% | 2045 |
|
2016
Q2 | $706K | Hold |
198,329
| – | – | ﹤0.01% | 2377 |
|
2016
Q1 | $585K | Sell |
198,329
-16,100
| -8% | -$47.5K | ﹤0.01% | 2354 |
|
2015
Q4 | $905K | Hold |
214,429
| – | – | ﹤0.01% | 2181 |
|
2015
Q3 | $978K | Sell |
214,429
-290
| -0.1% | -$1.32K | ﹤0.01% | 2178 |
|
2015
Q2 | $1.55M | Buy |
214,719
+16,100
| +8% | +$116K | ﹤0.01% | 1987 |
|
2015
Q1 | $1.46M | Sell |
198,619
-4,900
| -2% | -$36.1K | ﹤0.01% | 1945 |
|
2014
Q4 | $963K | Hold |
203,519
| – | – | ﹤0.01% | 2215 |
|
2014
Q3 | $727K | Sell |
203,519
-2,574
| -1% | -$9.2K | ﹤0.01% | 2363 |
|
2014
Q2 | $940K | Hold |
206,093
| – | – | ﹤0.01% | 2277 |
|
2014
Q1 | $969K | Hold |
206,093
| – | – | ﹤0.01% | 2170 |
|
2013
Q4 | $1.03M | Sell |
206,093
-38
| -0% | -$190 | ﹤0.01% | 2125 |
|
2013
Q3 | $1.28M | Sell |
206,131
-1,288
| -0.6% | -$8.01K | ﹤0.01% | 1976 |
|
2013
Q2 | $942K | Buy |
+207,419
| New | +$942K | ﹤0.01% | 2107 |
|